Although miR-548 has not been reported in CNS tumors including PCNSL, the miR-548 acts as an anti-oncogenic factor inhibiting the phosphoinositide 3-kinase (PI3K)/AKT signaling pathway in lung cancer [36] and associated with high-risk Gleason scores in prostate cancer [37]. This evidence concerns the gene AKT1 and lung cancer.